Is AI the Cancer-Fighting Tool We've been Waiting For?
As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against this complex disease.
Stay updated with breaking news from Jeff Bluestone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against this complex disease.
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointments of Joseph R. Arron, M.D., Ph.D., as Chief...
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone paymentTARRYTOWN,... | March 28, 2023
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone payment ... | March 28, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!